PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.\', \'Institute of Medical Virology, University of Zurich, Zurich, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.\', \'Institute of Medical Virology, University of Zurich, Zurich, Switzerland.\', \'Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.\', \'Department of Immunology, University Hospital Zurich, Zurich, Switzerland.\', \'Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland. Electronic address: antoniamaria.mueller@usz.ch.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2666-6367(22)00039-210.1016/j.jtct.2022.01.019
?:doi
?:hasPublicationType
?:journal
  • Transplantation and cellular therapy
is ?:pmid of
?:pmid
?:pmid
  • 35092892
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all